Immunohistochemical staining of AGR2 was also performed on different ovarian tissues, showing that AGR2 was expressed in 78.6% of ovarian carcinomas, 100% of BOTs and 0% of normal ovarian epithelium. Here, AGR2 is linked to ovarian carcinoma.